/

Other

/

Amneal Pharmaceuticals

Amneal Pharmaceuticals

Amneal Pharmaceuticals

Verified Nov 2026

Other

·

United States flag

Bridgewater, New Jersey

·

Since 2002

Amneal Pharmaceuticals manufactures generic, specialty, and biosimilar medicines from its headquarters in Bridgewater, New Jersey. Founded in 2002, the company employs 5,000–10,000 people and generates estimated revenue of $1–5 billion. Amneal produces approximately 300 products across oral solids, sterile injectables, and liquids, delivering over 160 million prescriptions annually to wholesalers, pharmacies, hospitals, and government agencies. In August 2026, the company completed its acquisition of Kashiv BioSciences to expand its biosimilar capabilities.

Amneal Pharmaceuticals

Verified Nov 2026

AT A GLANCE

Founded

2002

Headquarters

United States flag

Bridgewater, New Jersey

Employees

5,000-10,000

Ownership

Amneal Pharmaceuticals at a glance

Revenue

$1-5B

Est. band

Employees

5,000-10,000

Founded

2002

Headquarters

Bridgewater, New Jersey

Import activity

5935

Industries

Automotive

Electric Vehicles

Medical

Industrial Equipment

Sourcing and import activity

From US customs bill-of-lading records

US sea imports

5935

Named foreign suppliers

50

Top origins

India · Taiwan · Sri Lanka · Netherlands

Chart of the supplier's US import shipment volume trend over time

Shared foreign counterparties do not establish that these companies buy from Amneal Pharmaceuticals.

What this tells a buyer

Amneal recorded 5,935 shipments across 22 origin countries, with India accounting for 4,427 shipments from Amneal's own operations and additional inbound flow from suppliers including Granules India (9,986 shipments) and Divis Laboratories (2,348 shipments).

The company manufactures oral solids, sterile injectables, liquids, and complex generics, with operations in the United States, India, and Ireland supporting its product portfolio.

Amneal is privately held and ranks among generic drug manufacturers in the United States, with facilities in Brookhaven, New York and India.

Source: US customs bill-of-lading records and public filings · Last verified Nov 13, 2026

STABILITY SIGNALS

Established & active

24 years in operation (founded 2002).

5,935 US import shipments on record.

Overview

Amneal Pharmaceuticals manufactures generic, specialty, and biosimilar medicines from its headquarters in Bridgewater, New Jersey. Founded in 2002, the company employs 5,000–10,000 people and generates estimated revenue of $1–5 billion. Amneal produces approximately 300 products across oral solids, sterile injectables, and liquids, delivering over 160 million prescriptions annually to wholesalers, pharmacies, hospitals, and government agencies. In August 2026, the company completed its acquisition of Kashiv BioSciences to expand its biosimilar capabilities.

At a glance

Attribute

Detail

Founded

2002

Headquarters

Bridgewater, New Jersey

Employees

5,000-10,000

Revenue

$1-5B (estimated)

What Amneal Pharmaceuticals makes

The company manufactures oral solids, sterile injectables, liquids, and complex generics, with operations in the United States, India, and Ireland supporting its product portfolio.

Products and capabilities described on the company's own site include Seal, Extrusion (source: amneal.com).

Trade and customs footprint

Amneal recorded 5,935 shipments across 22 origin countries, with India accounting for 4,427 shipments from Amneal's own operations and additional inbound flow from suppliers including Granules India (9,986 shipments) and Divis Laboratories (2,348 shipments). US customs bill-of-lading records list 5935 inbound shipments across 50 foreign suppliers, with top origins including India · Taiwan · Sri Lanka · Netherlands.

Latest developments

Facilities

Amneal Pharmaceuticals is headquartered in Bridgewater, New Jersey. Public sources also reference these locations:

Company details

Amneal is privately held and ranks among generic drug manufacturers in the United States, with facilities in Brookhaven, New York and India. Amneal Pharmaceuticals was founded in 2002, has an estimated 5,000-10,000 employees, and is headquartered in Bridgewater, New Jersey. On the LightSource stability read it is rated "Established & active": 24 years in operation (founded 2002). 5,935 US import shipments on record.

Frequently asked questions

What does Amneal Pharmaceuticals do?

Amneal Pharmaceuticals manufactures generic, specialty, and biosimilar medicines from its headquarters in Bridgewater, New Jersey. Founded in 2002, the company employs 5,000–10,000 people and generates estimated revenue of $1–5 billion. Amneal produces approximately 300 products across oral solids, sterile injectables, and liquids, delivering over 160 million prescriptions annually to wholesalers, pharmacies, hospitals, and government agencies. In August 2026, the company completed its acquisition of Kashiv BioSciences to expand its biosimilar capabilities.

Where is Amneal Pharmaceuticals headquartered?

Amneal Pharmaceuticals is headquartered in Bridgewater, New Jersey (400 Crossing Boulevard, Bridgewater, New Jersey, 08807).

When was Amneal Pharmaceuticals founded?

Amneal Pharmaceuticals was founded in 2002.

How big is Amneal Pharmaceuticals?

Amneal Pharmaceuticals has an estimated 5,000-10,000 employees, with revenue in the $1-5B range (estimated).

Does Amneal Pharmaceuticals import from overseas suppliers?

US customs bill-of-lading records show 5935 inbound shipments for Amneal Pharmaceuticals, with top origins including India · Taiwan · Sri Lanka · Netherlands.

Related suppliers

Explore other suppliers in the LightSource directory:

Last verified Nov 2026. Is this your company? Request a correction.

Location & contact

Bridgewater, New Jersey (HQ)Headquarters · United States
Bridgewater, New Jersey (HQ)400 Crossing Boulevard, Bridgewater, New Jersey, 08807, United StatesHeadquarters

Evaluating suppliers like these?

This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.